Generic drugs can go through a bioequivalence (BE) study to determine if they have the same safety and efficacy of the innovator (brand-name) drugs, the Food and Drug Administration (FDA) said yesterday, as it clarified four common misconceptions about generic drugs.
When a brand-name drug’s patent expires, other companies can start selling generic versions of the drug, FDA Medicinal Product Division deputy head Lin Yi-chu (林意筑) said.
Of the 23,472 FDA-issued drug permit licenses that are currently valid, 17,510 are for generic drugs, or about 74 percent, Lin said.
Photo: CNA
A drug company that applies for a drug permit license for a generic drug with the same active ingredient, dosage form (the physical form in which a drug is administered) and dosage as a brand-name drug, needs to go through a BE study to prove that its safety and efficacy are the same as the brand-name drug, she said.
However, many people have misconceptions about generic drugs, including that they have not undergone clinical trials, their efficacy is only about 80 percent of the brand-name drugs, attending a BE study is a means to earn money, or that anyone can become a BE study participant, FDA Deputy Director-General Wang Der-yuan (王德原) said.
When an oral drug is administered, it is mainly absorbed in the intestines. In a BE study, blood tests are then taken to determine if the same amount of the active ingredient is released into the blood stream at the same rate as the brand-name drug, Lin said.
The mean values of the pharmacokinetic parameters of both medicinal products are compared and the 90 percent confidence intervals (CIs) are calculated. If the CIs are contained between 80 percent and 125 percent, the BE is demonstrated, she said, adding that this is an internationally agreed upon standard.
A BE study is a type of clinical research. The brand-name drug has already been proven safe and effective, so if the generic drug is proven to be bioequivalent to its brand-name counterpart, its safety and efficacy are also proven, Taiwan Association of Institutional Review Boards chairperson Chang Fung-wei (張芳維) said.
Participants of BE studies do not earn money, but the study organizers usually provide transportation, meals and nutrition fees, he said.
After a drug company gets an institutional review board approval for its BE study, it would send an informed consent form to participants. Those participants are required to strictly follow the instructions detailed in the form, including limits on eating certain foods or taking other drugs, Chang said.
The entire study process must also follow the good clinical practice guidelines to ensure the reliability of clinical trial results and the protection of patients, he added.
In addition, BE study participants must be healthy adults, and there are usually eligibility criteria, such as age, gender and body mass index (BMI) range among others, as well as the exclusion of people with chronic or acute illnesses, pregnant or breast-feeding women, and those taking certain prescription drugs, Chang said.
Taiwan is to have nine extended holidays next year, led by a nine-day Lunar New Year break, the Cabinet announced yesterday. The nine-day Lunar New Year holiday next year matches the length of this year’s holiday, which featured six extended holidays. The increase in extended holidays is due to the Act on the Implementation of Commemorative and Festival Holidays (紀念日及節日實施條例), which was passed early last month with support from the opposition Chinese Nationalist Party (KMT) and Taiwan People’s Party. Under the new act, the day before Lunar New Year’s Eve is also a national holiday, and Labor Day would no longer be limited
COMMITMENTS: The company had a relatively low renewable ratio at 56 percent and did not have any goal to achieve 100 percent renewable energy, the report said Pegatron Corp ranked the lowest among five major final assembly suppliers in progressing toward Apple Inc’s commitment to be 100 percent carbon neutral by 2030, a Greenpeace East Asia report said yesterday. While Apple has set the goal of using 100 percent renewable energy across its entire business, supply chain and product lifecycle by 2030, carbon emissions from electronics manufacturing are rising globally due to increased energy consumption, it said. Given that carbon emissions from its supply chain accounted for more than half of its total emissions last year, Greenpeace East Asia evaluated the green transition performance of Apple’s five largest final
Taiwan is to extend its visa-waiver program for Philippine passport holders for another year, starting on Aug. 1, Minister of Foreign Affairs Lin Chia-lung (林佳龍) said on Friday. Lin made the announcement during a reception in Taipei marking the 127th anniversary of Philippine independence and the 50th anniversary of the establishment of the Manila Economic and Cultural Office (MECO) in Taiwan, the Ministry of Foreign Affairs said. The decision reflected Taiwan’s commitment to deepening exchanges with the Philippines, the statement cited Lin as saying, adding that it was a key partner under the New Southbound Policy launched in 2016. Lin also expressed hope
Temperatures in New Taipei City’s Sindian District (新店) climbed past 37°C yesterday, as the Central Weather Administration (CWA) issued heat alerts for 16 municipalities, warning the public of intense heat expected across Taiwan. The hottest location in Taiwan was in Sindian, where the mercury reached 37.5°C at about 2pm, according to CWA data. Taipei’s Shilin District (士林) recorded a temperature of 37.4°C at noon, Taitung County’s Jinfeng Township (金峰) at 12:50 pm logged a temperature of 37.4°C and Miaoli County’s Toufen Township (頭份) reached 36.7°C at 11:40am, the CWA said. The weather agency yesterday issued a yellow level information notice for Taipei, New
RSS